What are the typical MRI findings of low‑grade glioma in a 20‑40‑year‑old adult presenting with seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MRI Characteristics of Low-Grade Glioma

Low-grade gliomas in young adults presenting with seizures typically appear as nonenhancing, T2/FLAIR hyperintense lesions without mass effect or surrounding edema on MRI. 1

Core Anatomic Imaging Features

Essential MRI sequences for identifying low-grade gliomas include T1-weighted (pre- and post-gadolinium), T2-weighted, and FLAIR imaging. 2 These sequences form the minimum diagnostic standard for suspected brain tumors. 2

T1-Weighted Characteristics

  • Hypointense (low signal) on non-contrast T1-weighted images 1
  • Typically non-enhancing after gadolinium administration, distinguishing them from high-grade gliomas 1
  • Lack of contrast enhancement is a hallmark feature in most low-grade gliomas 1

T2-Weighted and FLAIR Characteristics

  • Hyperintense (bright) signal on T2-weighted and FLAIR sequences 1, 2
  • Well-demarcated appearance, particularly in oligodendrogliomas 1
  • Solid, homogeneous signal intensity without significant heterogeneity 1

Additional Structural Features

  • Absence of mass effect despite potentially large tumor size 1
  • No peritumoural edema, which helps differentiate from high-grade tumors 1
  • Low-attenuation on CT imaging when this modality is used 1

Tumor-Specific Imaging Patterns

Oligodendrogliomas

  • Calcifications present in over one-third of cases, best visualized on CT 1
  • Well-demarcated borders with sharp margins 1
  • Cortical location with potential skull remodeling (44% of cases) 1

Astrocytomas

  • Poorly circumscribed and infiltrative appearance 1
  • More diffuse borders compared to oligodendrogliomas 1
  • Less likely to contain calcifications 1

Advanced Imaging Characteristics

Perfusion MRI Findings

Low cerebral blood volume (rCBV) with values typically <1.75 distinguishes low-grade from high-grade gliomas. 3 The average rCBV for low-grade gliomas is approximately 1.29 (range 0.01-5.10), significantly lower than high-grade tumors. 3

Dynamic susceptibility contrast (DSC) perfusion imaging shows:

  • Minimal tumor perfusion reflecting low angiogenesis 2
  • Absence of increased vascular permeability 3
  • Hypoperfusion on interictal SPECT imaging 1

Metabolic Imaging

FDG-PET demonstrates glucose hypometabolism in low-grade gliomas, showing minimal metabolic activity. 1 This contrasts sharply with high-grade tumors that show increased glucose uptake. 1

MET-PET shows minimal or absent uptake of 11C-methionine, which is highly suggestive of low-grade pathology when combined with slowly progressive clinical course. 1

MR Spectroscopy

  • Loss of N-acetylaspartate (NAA) is less pronounced than in high-grade gliomas 1
  • Choline elevation is present but less dramatic than high-grade tumors 1
  • May help identify progression to higher grade when serial studies show increasing choline 2

Critical Differential Diagnosis Considerations

Low-grade gliomas must be distinguished from focal cortical dysplasia (FCD), which can have overlapping imaging features in seizure patients. 1 Key differentiating features include:

  • FCD shows blurring of grey-white matter junction more prominently 1
  • Transmantle sign (radially oriented T2/FLAIR hyperintensity pointing to ventricle) is specific for FCD type IIb, not glioma 1
  • FCD demonstrates cortical thickening and abnormal gyral patterns 1

Dysembryoplastic neuroepithelial tumors (DNETs) are another important differential:

  • Intracortical location without mass effect (similar to low-grade glioma) 1
  • May show skull deformity overlying the lesion 1
  • Hypoperfusion on interictal SPECT with epileptogenic cortex surrounding (not within) the lesion 1

Gangliogliomas can mimic low-grade gliomas and represent a key histological differential diagnosis. 1

Surveillance Imaging Protocol

Serial T2/FLAIR sequences are essential for monitoring tumor growth and detecting malignant transformation. 1, 2 Follow-up imaging should be performed every 3-6 months initially. 1

New contrast enhancement or significant size increase signals potential transformation to higher grade, requiring immediate clinical action. 1, 2 This represents a critical imaging milestone that changes management from observation to intervention. 1

Common Pitfalls

Approximately 21% of low-grade gliomas show some contrast enhancement, which can lead to misclassification as high-grade tumors. 1 Clinical context and perfusion characteristics help resolve this ambiguity. 3

Small cystic components occur in 7.5% of cases, which should not automatically suggest higher grade pathology. 1

Biopsy sampling error is significant because gliomas have regional heterogeneity, and small samples may underestimate grade. 1 Imaging-guided targeting of areas with highest perfusion improves diagnostic accuracy. 2

High-grade gliomas occasionally present without enhancement, mimicking low-grade tumors on conventional MRI. 3 Perfusion imaging showing rCBV >1.75 helps identify these cases. 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.